Clinical Trials
24 trialsmRNA-LNP
IntraAb, Inc.
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
Biotech Pharmaceutical Co., Ltd.
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
OncoC4, Inc.
Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Nanjing Immunophage Biotech Co., Ltd
Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study of MG2512 Injection in Participants With Advanced Solid Tumors
Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.
A Clinical Study of ZL-85FA Tablets
Chengdu Zenitar Biomedical Technology Co., Ltd
CVL006-T1002
Convalife (Shanghai) Co., Ltd.
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation
Shouyao Holdings (Beijing) Co. LTD
A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours
LaNova Medicines Limited
A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
A Study of AK-1286 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Clinical Study of CVL006 Injection in Advanced Solid Tumors
Convalife (Shanghai) Co., Ltd.
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.
Hansoh BioMedical R&D Company
A Study of Simmitinib Plus SG001 in Advanced Solid Tumors
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor
Peking University
A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors
Suzhou Neologics Bioscience Co., Ltd.
A Study of KM602 in Patients With Advanced Solid Tumors
Xuanzhu Biopharmaceutical Co., Ltd.
Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors
Minghui Pharmaceutical Pty Ltd
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor
The Affiliated Hospital of Qingdao University
A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors.
Xuanzhu Biopharmaceutical Co., Ltd.